Radiotherapy Market by Technology (EBRT: LINAC, Stereotactic, Particle; Internal Beam/Brachytherapy, Cobalt-60 Teletherapy), Procedure (IGRT, IMRT, 3D-CRT, LDR, PDR), Cancer (Prostate, Lung, Breast, CRC), End User (Hospital, IRC) - Global Forecast to 2031

Market Size
$7.98B
MARKET SIZE, 2026
Projected Market Size
$10.68B
MARKET SIZE, 2031
CAGR
6.0%
CAGR (2026-2031)
Forecast Period
2026-2031
FORECAST PERIOD

RADIOTHERAPY MARKET SIZE, SHARE & GROWTH SNAPSHOT

radiotherapy-monitoring-devices-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global radiotherapy market is projected to grow from USD 7.98 billion in 2026 to USD 10.68 billion by 2031, at a CAGR of 6.0% during the forecast period. The market was valued at USD 7.58 billion in 2025. The growth of the radiotherapy market is driven by several factors, including the rising global incidence of cancer, increased spending on healthcare facilities, and growing demand for precision oncology treatments. The rapid adoption of innovative applications such as proton beam therapy, adaptive radiotherapy, stereotactic radiosurgery, and artificial intelligence-based treatment planning is improving the accuracy of tumor treatment while minimizing damage to surrounding tissues.

KEY TAKEAWAYS

  • MARKET SNAPSHOT:
    Base Year Market Size (2025): USD 7.58 Billion
    Current Market Size (2026): USD 7.98 Billion
    Forecast Market Size (2031): USD 10.68 Billion
    CAGR (2026–2031): 6.0%
  • SEGMENT LEADERSHIP:
    Regional Outlook: Asia Pacific is projected to witness the highest CAGR of 7.1% during the forecast period.
    Offering Leader: Systems segment accounted for the largest market share of 55.5% in 2025.
    Technology Leader: External beam radiotherapy segment is expected to register the highest CAGR of 5.7% during the forecast period.
    Application Leader: EBRT applications segment dominated the market with a share of 96.0% in 2025.
    Procedure Leader: External beam radiotherapy procedures segment accounted for the largest market share of 96.0% in 2025.
    End User Leader: Hospitals segment is projected to grow at the fastest rate of 5.7% from 2026 to 2031.
  • MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
    Siemens Healthineers AG (Varian Medical Systems, Inc.) (Germany), Elekta (Sweden), Accuray Incorporated (US), IBA Worldwide (Belgium), and ViewRay, Inc. (US) are identified as star players in the radiotherapy market, given their strong global market presence, extensive portfolios, advanced R&D capabilities, and well-established distribution networks across developed and emerging regions.
    Brainlab AG (Germany) and BEBIG Medical (Germany) are among the successful startups and SMEs offering specialized radiotherapy solutions and strengthening their positions in niche segments.

The growth of the radiotherapy market is driven by several factors, including the rising global incidence of cancer, increased healthcare spending, and a growing demand for precision oncology treatments. The rapid adoption of advanced applications such as proton beam therapy, adaptive radiotherapy, stereotactic radiosurgery, and artificial intelligence-based treatment planning is improving the accuracy of tumor treatment while minimizing damage to surrounding tissues.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

Several technological developments and trends are likely to significantly impact the radiotherapy market. Key advancements include sophisticated technologies such as Linear Accelerators (LINACs), proton therapy systems, MRI-guided radiotherapy systems, and stereotactic radiotherapy systems. Additionally, innovations such as artificial intelligence-based treatment-planning solutions, workflow optimization tools, and real-time tumor-tracking systems are expected to shape the market's future. The primary goal of these technological advancements is to enhance the efficacy of radiotherapy procedures. Recently, hypofractionated radiotherapy and image-guided treatment procedures have gained increasing popularity.

radiotherapy-monitoring-devices-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Advancements in radiotherapy treatments
  • Increasing use of advanced applications, including adaptive radiotherapy, stereotactic body radiation therapy (SBRT), and MRI-guided radiotherapy
RESTRAINTS
Impact
Level
  • Limited access to advanced radiotherapy facilities in low- and middle-income countries
  • Shortage of skilled radiation oncologists, medical physicists, and trained technicians
OPPORTUNITIES
Impact
Level
  • Emerging markets offering significant growth potential for radiotherapy technologies
  • AI-based treatment planning, automated contouring, and adaptive radiotherapy
CHALLENGES
Impact
Level
  • Regulatory complexity and lengthy approval timelines for advanced radiotherapy technologies
  • Managing treatment accuracy for moving tumors through real-time imaging and motion tracking

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Advancements in radiotherapy treatments

Technological advancements in radiotherapy have become a key factor driving the growth of the radiotherapy market. The increasing adoption of advanced treatment technologies, such as intensity-modulated radiation therapy (IMRT), stereotactic body radiation therapy (SBRT), MRI-guided linear accelerators (MRI-guided LINACs), adaptive radiotherapy, and AI-based treatment planning software, is significantly improving the precision of radiation doses, the accuracy of tumor targeting, and overall treatment efficiency while minimizing exposure to surrounding healthy tissues. Furthermore, the shift from conventional 2D radiotherapy to real-time image-guided and 3D conformal radiotherapy systems is enhancing clinical outcomes and broadening the applications of radiotherapy across hospitals and cancer care centers. Recent innovations, including AI-powered adaptive CT-LINAC systems, robotic radiosurgery platforms, and real-time motion tracking technologies, are further accelerating the global adoption of advanced radiotherapy solutions.

Restraint: Limited access to advanced radiotherapy facilities in low- and middle-income countries

Limited access to advanced radiotherapy facilities in low- and middle-income countries poses a significant barrier to the radiotherapy market. This issue stems from inadequate healthcare infrastructure, a shortage of skilled oncology professionals, and the high costs associated with advanced radiotherapy systems. Many healthcare facilities in emerging regions struggle to adopt technologies such as proton therapy, MRI-guided radiotherapy, and adaptive radiotherapy due to limited funding and insufficient reimbursement support. Additionally, the uneven distribution of cancer care centers and the delayed installation of advanced treatment systems continue to hinder patient access to precision oncology services. However, emerging trends like compact linear accelerator systems, AI-assisted treatment planning, cloud-based oncology workflows, and mobile radiotherapy solutions are expected to gradually enhance accessibility and operational efficiency in underserved regions.

Opportunity: Emerging markets offering significant growth potential for radiotherapy technologies

Emerging economies offer significant growth opportunities for the radiotherapy market due to the rising prevalence of cancer, improved healthcare infrastructure, and increased investments in oncology care in countries such as China, India, Brazil, and Mexico. Governments in these regions are boosting healthcare spending and enhancing access to advanced cancer treatment technologies. It is projected that government health expenditures will grow by 14% in low-income countries (LICs) and 17% in lower-middle-income countries (LMICs) between 2024 and 2030, which will support the expansion of radiotherapy infrastructure and oncology services. Additionally, the rise of medical tourism, lower treatment costs compared to developed countries, and the increasing adoption of advanced technologies such as AI-enabled radiotherapy, CyberKnife radiosurgery, and proton therapy are creating further significant growth opportunities for the radiotherapy market in emerging economies.

Challenge: Regulatory complexity and lengthy approval timelines for advanced radiotherapy technologies

Regulatory complexity and lengthy approval timelines for advanced radiotherapy technologies pose significant challenges for the radiotherapy market. Advanced systems, such as proton therapy, MRI-guided radiotherapy, adaptive radiotherapy platforms, and AI-based treatment planning software, require extensive clinical validation, safety assessments, and adherence to stringent regulatory standards before they can be commercialized. Variations in regulatory frameworks across different regions further prolong approval timelines and delay the launch of products for market players. Additionally, evolving regulations concerning AI integration, radiation safety, and software interoperability create ongoing operational and compliance challenges for manufacturers developing next-generation radiotherapy solutions.

RADIOTHERAPY MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Provides Varian LINACs and AI-enabled adaptive radiotherapy solutions. Improves treatment precision and adaptive workflow efficiency.
Offers MRI-guided and adaptive radiotherapy systems. Enables real-time imaging and accurate tumor targeting.
Delivers CyberKnife and Radixact radiotherapy platforms. Supports robotic radiosurgery and motion-tracked treatment delivery.
Provides proton therapy and particle therapy solutions. Minimizes radiation exposure to surrounding healthy tissues.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The stakeholders in the radiotherapy market include manufacturers of radiotherapy systems, providers of software and treatment planning solutions, component suppliers, distributors, hospitals, independent radiotherapy centers, and regulatory authorities. Companies in this market are focused on developing advanced radiotherapy systems, such as linear accelerators (LINACs), MRI-guided radiotherapy systems, particle therapy systems, brachytherapy solutions, and AI-enabled treatment planning platforms to enhance treatment precision and improve clinical outcomes. Suppliers and service providers contribute to the market by delivering consumables, software integration, installation, maintenance, and workflow optimization services. Hospitals and independent radiotherapy centers are the primary end users due to the growing demand for advanced cancer treatment procedures. Regulatory bodies, such as the US Food and Drug Administration (FDA) and the European Medicines Agency (EMA), ensure the safety, efficacy, and approval of innovative radiotherapy technologies. Key companies operating within the radiotherapy ecosystem include Siemens Healthineers AG (Germany), Elekta (Sweden), Accuray Incorporated (US), IBA Worldwide (Belgium), Brainlab AG (Germany), and BEBIG Medical (Germany).

radiotherapy-monitoring-devices-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

RADIOTHERAPY MARKET, BY OFFERING

By offering, the radiotherapy market is divided into systems and software & services. The systems segment is expected to experience significant growth in the coming years due to the increasing popularity of technology-enabled radiotherapy equipment in developing countries and the rising number of manufacturers producing these advanced systems. This segment includes systems, consumables, probes, and applicators used in external beam radiation therapy and brachytherapy. Furthermore, the growing incidence of cancer, the increasing demand for precision radiotherapy, and ongoing advancements in technology are also contributing to the market's expansion.

RADIOTHERAPY MARKET, BY TECHNOLOGY

Based on technology, radiotherapy is segmented into external beam radiotherapy and internal beam radiotherapy/brachytherapy. The external beam radiotherapy segment is anticipated to have the largest market share among other segments during the forecast period, owing to its capability of providing highly accurate and precise tumor targeting without exposing adjacent healthy tissue to any unnecessary radiation. Growth in the adoption of more advanced procedures and increased demand for precision medicine are driving the growth of this segment.

RADIOTHERAPY MARKET, BY APPLICATION

By application, the radiotherapy market is segmented into external beam radiotherapy (EBRT) applications and internal beam radiotherapy (IBRT)/brachytherapy applications. During the forecast period, the external beam radiotherapy (EBRT) applications segment is poised to command the most substantial market share in the radiotherapy market. This dominance is fueled by the increasing adoption and efficacy of EBRT for new cancer types.

RADIOTHERAPY MARKET, BY PROCEDURE

By procedure, the radiotherapy market is segmented into external beam radiotherapy procedures and internal beam radiotherapy/brachytherapy procedures. The external beam radiotherapy procedures segment is estimated to dominate the radiotherapy market during the forecast period, owing to the non-invasive nature of this procedure, high degree of accuracy, low radiation exposure to nearby healthy cells, and increasing adoption of advanced technology-based devices. The rising requirement for personal cancer treatment, high incidence of cancer, and technological innovations are propelling the growth of this segment.

RADIOTHERAPY MARKET, BY END USER

On the basis of end user, the radiotherapy market is classified into hospitals and standalone radiotherapy centers. The hospitals segment will hold the largest share of the worldwide radiotherapy market in the coming years, due to the large volume of patients, availability of advanced radiotherapy equipment, and rising demand for complete cancer treatment facilities in hospitals. The other factors that will support the growth of this segment include the increasing number of hospitals in developing nations, investments in the healthcare infrastructure sector, and availability of trained oncologists.

REGION

Asia Pacific to be fastest-growing region in global radiotherapy market during forecast period

The Asia Pacific region is expected to register the highest CAGR in the radiotherapy market during the forecast period. Asia Pacific comprises China, India, South Korea, Australia, Japan, and the Rest of Asia Pacific. Growth is driven by the increasing prevalence of cancer, an aging population, expanding oncology infrastructure, and growing adoption of advanced radiotherapy equipment such as linear accelerators, image-guided radiation therapy, and proton therapy. Other factors driving the market include increased government spending, increased medical tourism, and collaborations between market vendors.

radiotherapy-monitoring-devices-market Region

RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX

The radiotherapy market is characterized by several established and emerging players operating across the Stars, Emerging Leaders, Pervasive Players, and Participants categories. Companies categorized as Stars, including Siemens Healthineers, Elekta, Accuray, IBA Worldwide, and ViewRay Technologies, hold strong market positions due to their broad product portfolios, advanced radiotherapy technologies, global presence, and strong focus on innovation in precision oncology, adaptive radiotherapy, proton therapy, and AI-enabled treatment planning. Emerging Leaders such as Sumitomo, Carl Zeiss, and Hitachi are strengthening their market presence through continuous technological advancements and specialized radiotherapy offerings. Pervasive Players, including Philips and Mevion, possess established business strategies and focused technology portfolios, particularly in imaging and proton therapy applications. Meanwhile, Participants such as MIM Software, Panacea Medical Technologies, Optivus Proton Therapy, Perspective Therapeutics, and Provision Healthcare are expanding their market presence through niche product offerings, software solutions, and specialized radiotherapy applications. Although these companies currently hold smaller market shares compared to leading players, their growing focus on innovation, strategic collaborations, and expansion into emerging application areas is expected to enhance their competitiveness in the global radiotherapy market.

radiotherapy-monitoring-devices-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 7.58 Billion
Market Forecast in 2026 (Value) USD 7.98 Billion
Market Forecast in 2031 (Value) USD 10.68 Billion
Growth Rate CAGR of 6.0% from 2026-2031
Years Considered 2024-2031
Base Year 2025
Forecast Period 2026-2031
Units Considered Value (USD Billion)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Technology:
    • LINACs
    • Particle Therapy
    • Conventional Cobalt-60 Teletherapy
  • By Offering:
    • Systems
    • Software & Services
  • By Application:
    • External Beam Radiotherapy Applications
    • Internal Beam Radiotherapy/Brachytherapy Applications
  • By Procedure:
    • External Beam Radiotherapy
    • Internal Beam Radiotherapy/Brachytherapy
  • By End User:
    • Hospitals
    • Standalone Radiotherapy Centers
Regions Covered North America, Asia Pacific, Europe, Latin America, Middle East & Africa

WHAT IS IN IT FOR YOU: RADIOTHERAPY MARKET REPORT CONTENT GUIDE

radiotherapy-monitoring-devices-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Radiotherapy System Manufacturer
  • Market sizing and growth forecast by technology (LINACs, particle therapy, conventional cobalt-60 teletherapy)
  • Procedure-wise analysis (external beam radiotherapy, internal beam radiotherapy/brachytherapy)
  • Application-wise analysis (external beam radiotherapy applications, internal beam radiotherapy/brachytherapy applications)
  • System and software & services assessment
  • End-user analysis (hospitals, independent radiotherapy centers)
  • Competitive benchmarking and regional market insights
  • Technology adoption trends and reimbursement landscape analysis
  • Identify high-growth opportunities across radiotherapy technologies and applications
  • Support product portfolio optimization and innovation strategies
  • Strengthen go-to-market and regional expansion plans
  • Assist in demand forecasting and capacity planning
  • Enhance competitive positioning and strategic decision-making
Hospitals/Independent Radiotherapy Centers
  • Technology utilization and procedure volume analysis across radiotherapy centers
  • Workflow and treatment planning assessment for external beam radiotherapy and brachytherapy
  • Evaluation of software, services, and treatment efficiency
  • Vendor comparison and equipment performance assessment
  • Cost considerations and procurement insights
  • Infrastructure and installation trend analysis
  • Improve operational efficiency and treatment workflow optimization
  • Support equipment purchasing and vendor selection decisions
  • Enhance patient treatment planning and resource allocation
  • Assist in expansion planning for radiotherapy facilities
  • Enable evidence-based investment and technology adoption decisions

RECENT DEVELOPMENTS

  • February 2025 : IBA Worldwide entered into an agreement with the Asian Institute of Gastroenterology (AIG) to provide a ProteusONE compact therapy system to support research in its oncology center.
  • January 2025 : Accuray Incorporated (US) received NMPA approval for the Radixact SynC System and the CyberKnife S7 System, which provide accurate and minimally invasive radiotherapy.
  • August 2024 : Accuray received CE Mark for the new Helical Radiation Delivery System.
  • May 2024 : Elekta launched the AI-powered adaptive CT-Linac, Evo, which is capable of delivering both offline and online adaptive radiation therapy, in addition to improving standard IGRT treatments.

 

Table of Contents

checkmarkExclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
29
2
EXECUTIVE SUMMARY
 
 
 
 
 
34
3
PREMIUM INSIGHTS
 
 
 
 
 
39
4
MARKET OVERVIEW
Unlock growth by leveraging AI-driven radiotherapy advancements amidst cost and access challenges.
 
 
 
 
 
42
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
ADVANCEMENTS IN RADIOTHERAPY TREATMENT
 
 
 
 
 
 
4.2.1.2
AI AND AUTOMATION IN TREATMENT PLANNING
 
 
 
 
 
 
4.2.1.3
INCREASING GOVERNMENT INVESTMENTS AND AWARENESS INITIATIVES FOR CANCER CARE
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
HIGH COSTS ASSOCIATED WITH RADIOTHERAPY SYSTEMS SUCH AS PROTON THERAPY AND ADVANCED LINEAR ACCELERATORS
 
 
 
 
 
 
4.2.2.2
LIMITED ACCESS TO ADVANCED RADIOTHERAPY INFRASTRUCTURE AND SKILLED WORKFORCE IN LOW- AND MIDDLE-INCOME COUNTRIES
 
 
 
 
 
 
4.2.2.3
SHORTAGE OF SKILLED RADIATION ONCOLOGISTS, MEDICAL PHYSICISTS, AND TRAINED TECHNICIANS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
EMERGING MARKETS OFFER SIGNIFICANT GROWTH POTENTIAL FOR RADIOTHERAPY TECHNOLOGIES
 
 
 
 
 
 
4.2.3.2
INTEGRATION OF RADIOTHERAPY WITH IMMUNOTHERAPY AND SYSTEMIC THERAPIES
 
 
 
 
 
 
4.2.3.3
GROWING ADOPTION OF OUTPATIENT RADIOTHERAPY AND HYPOFRACTIONATED TREATMENT REGIMENS
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
INCREASING CYBERSECURITY AND DATA PROTECTION CHALLENGES IN DIGITAL RADIOTHERAPY ECOSYSTEMS
 
 
 
 
 
 
4.2.4.2
PATIENT SAFETY CONCERNS AND RADIATION EXPOSURE RISKS
 
 
 
 
4.3
UNMET NEEDS
 
 
 
 
 
 
4.4
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
Navigate competitive dynamics and macroeconomic shifts shaping the global radiotherapy industry's future.
 
 
 
 
 
54
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
 
5.1.2
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.4
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.5
THREAT OF NEW ENTRANTS
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
 
5.2.1
GDP TRENDS AND FORECAST
 
 
 
 
 
 
5.2.2
TRENDS IN GLOBAL RADIOTHERAPY INDUSTRY
 
 
 
 
 
5.3
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
 
5.3.1
RESEARCH & DEVELOPMENT
 
 
 
 
 
 
5.3.2
PROCUREMENT & MANUFACTURING
 
 
 
 
 
 
5.3.3
MARKETING, SALES, AND DISTRIBUTION
 
 
 
 
 
5.4
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
5.5
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.5.1
AVERAGE SELLING PRICE TREND, BY REGION
 
 
 
 
 
5.6
TRADE ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
IMPORT DATA (HS CODE 902214)
 
 
 
 
 
 
5.6.2
EXPORT DATA (HS CODE 902214)
 
 
 
 
 
5.7
KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
5.8
TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
5.9
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
 
5.10
CASE STUDY ANALYSIS
 
 
 
 
 
 
 
5.10.1
SBRT’S ROLE IN MINIMIZING RADIATION RISK IN ELDERLY PATIENTS
 
 
 
 
 
 
5.10.2
RADIOTHERAPY FOR BREAST CANCER IN PATIENTS WITH HEREDITARY COPROPORPHYRIA
 
 
 
 
 
 
5.10.3
RADIATION THERAPY TREATMENT FOR TRANSITIONAL CELL CARCINOMA OF DISTAL URETHRA
 
 
 
 
 
5.11
IMPACT OF 2025 US TARIFF - RADIOTHERAPY MARKET
 
 
 
 
 
 
 
 
5.11.1
KEY TARIFF RATES
 
 
 
 
 
 
5.11.2
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.11.3
IMPACT ON COUNTRIES/REGIONS
 
 
 
 
 
 
5.11.4
IMPACT ON END-USE INDUSTRIES
 
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI-driven innovations redefine radiotherapy with adaptive, cloud-based, and patent-rich technologies.
 
 
 
 
 
72
 
6.1
KEY TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1
MR-GUIDED ADAPTIVE RADIOTHERAPY
 
 
 
 
 
 
6.1.2
ARTIFICIAL INTELLIGENCE-DRIVEN TREATMENT PLANNING
 
 
 
 
 
 
6.1.3
PROTON AND PARTICLE THERAPY
 
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.2.1
ADVANCED TREATMENT PLANNING SYSTEMS AND AI-ENABLED DECISION SUPPORT
 
 
 
 
 
 
6.2.2
CLOUD-BASED AND REMOTE RADIOTHERAPY PLATFORMS
 
 
 
 
 
6.3
PATENT ANALYSIS
 
 
 
 
 
 
 
 
6.3.1
INNOVATIONS AND PATENT REGISTRATIONS
 
 
 
 
 
6.4
FUTURE APPLICATIONS
 
 
 
 
 
 
6.5
IMPACT OF AI/GEN AI ON RADIOTHERAPY MARKET
 
 
 
 
 
 
 
 
6.5.1
TOP USE CASES AND MARKET POTENTIAL
 
 
 
 
 
 
6.5.2
BEST PRACTICES FOLLOWED BY MANUFACTURERS IN RADIOTHERAPY MARKET
 
 
 
 
 
 
6.5.3
CASE STUDIES RELATED TO AI IMPLEMENTATION IN RADIOTHERAPY MARKET
 
 
 
 
 
 
6.5.4
INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
6.5.5
CLIENT'S READINESS TO ADOPT GENERATIVE AI IN RADIOTHERAPY MARKET
 
 
 
 
 
6.6
SUCCESS STORIES AND REAL-WORLD APPLICATIONS
 
 
 
 
 
7
REGULATORY LANDSCAPE
Navigate global compliance with insights on regional regulations and key industry standards.
 
 
 
 
 
84
 
7.1
REGIONAL REGULATIONS AND COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
 
 
 
7.1.2.1
NORTH AMERICA
 
 
 
 
 
 
 
 
7.1.2.1.1
US
 
 
 
 
 
 
7.1.2.1.2
CANADA
 
 
 
 
7.1.2.2
EUROPE
 
 
 
 
 
 
7.1.2.3
ASIA PACIFIC
 
 
 
 
 
 
 
 
7.1.2.3.1
CHINA
 
 
 
 
 
 
7.1.2.3.2
JAPAN
 
 
 
 
 
 
7.1.2.3.3
INDIA
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Understand key stakeholder roles and unmet needs shaping radiotherapy system purchases.
 
 
 
 
 
91
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.2
KEY STAKEHOLDERS INVOLVED IN BUYING PROCESS AND THEIR EVALUATION CRITERIA
 
 
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.2.2
BUYING CRITERIA
 
 
 
 
 
8.3
ADOPTION BARRIERS AND INTERNAL CHALLENGES
 
 
 
 
 
 
8.4
UNMET NEEDS FROM END-USERS
 
 
 
 
 
9
RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 3 Data Tables
 
 
 
 
 
95
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
SYSTEMS
 
 
 
 
 
 
 
9.2.1
INCREASING ADOPTION OF AI-ENABLED AND IMAGE-GUIDED RADIOTHERAPY SYSTEMS TO DRIVE GROWTH
 
 
 
 
 
9.3
SOFTWARE & SERVICES
 
 
 
 
 
 
 
9.3.1
INCREASING ADOPTION OF INTEGRATED ONCOLOGY SOFTWARE PLATFORMS TO SUPPORT MARKET GROWTH
 
 
 
 
10
RADIOTHERAPY MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 17 Data Tables
 
 
 
 
 
99
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
EXTERNAL BEAM RADIOTHERAPY
 
 
 
 
 
 
 
10.2.1
PROSTATE CANCER
 
 
 
 
 
 
 
10.2.1.1
HIGH INCIDENCE RATE AND EFFICIENCY OF EBRT IN PROSTATE CANCER TREATMENT TO SUPPORT GROWTH
 
 
 
 
 
10.2.2
BREAST CANCER
 
 
 
 
 
 
 
10.2.2.1
THERAPEUTIC BENEFITS OF EBRT TO DRIVE MARKET
 
 
 
 
 
10.2.3
LUNG CANCER
 
 
 
 
 
 
 
10.2.3.1
HIGH PREVALENCE OF LUNG CANCER AND EFFICIENCY OF EBRT TO DRIVE MARKET
 
 
 
 
 
10.2.4
HEAD & NECK CANCER
 
 
 
 
 
 
 
10.2.4.1
INCREASING PREFERENCE FOR NONINVASIVE TREATMENT OF HEAD & NECK CANCERS TO DRIVE MARKET
 
 
 
 
 
10.2.5
COLORECTAL CANCER
 
 
 
 
 
 
 
10.2.5.1
HIGH INCIDENCE OF COLORECTAL CANCER TO SUPPORT MARKET GROWTH
 
 
 
 
 
10.2.6
OTHER EBRT APPLICATIONS
 
 
 
 
 
10.3
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
 
 
 
 
 
 
 
10.3.1
PROSTATE CANCER
 
 
 
 
 
 
 
10.3.1.1
PRECISION OF BRACHYTHERAPY TO DRIVE MARKET
 
 
 
 
 
10.3.2
GYNECOLOGICAL CANCER
 
 
 
 
 
 
 
10.3.2.1
AVAILABILITY OF ALTERNATIVES TO HINDER ADOPTION OF BRACHYTHERAPY
 
 
 
 
 
10.3.3
BREAST CANCER
 
 
 
 
 
 
 
10.3.3.1
GROWING ADOPTION OF ACCELERATED PARTIAL BREAST IRRADIATION DRIVES BREAST BRACHYTHERAPY UTILIZATION
 
 
 
 
 
10.3.4
CERVICAL CANCER
 
 
 
 
 
 
 
10.3.4.1
MRI-GUIDED ADAPTIVE BRACHYTHERAPY AND AI-ENABLED PLANNING DRIVE ADVANCES IN CERVICAL CANCER TREATMENT
 
 
 
 
 
10.3.5
PENILE CANCER
 
 
 
 
 
 
 
10.3.5.1
INCREASING AWARENESS OF ORGAN-PRESERVATION STRATEGIES TO DRIVE MARKET
 
 
 
 
 
10.3.6
OTHER IBRT APPLICATIONS
 
 
 
 
11
RADIOTHERAPY MARKET, BY PROCEDURE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 14 Data Tables
 
 
 
 
 
114
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
EXTERNAL BEAM RADIOTHERAPY
 
 
 
 
 
 
 
11.2.1
IMAGE-GUIDED RADIOTHERAPY
 
 
 
 
 
 
 
11.2.1.1
GROWING ADOPTION OF REAL-TIME IMAGING AND ADAPTIVE WORKFLOWS TO SUPPORT MARKET GROWTH
 
 
 
 
 
11.2.2
INTENSITY-MODULATED RADIOTHERAPY
 
 
 
 
 
 
 
11.2.2.1
GROWING ADOPTION OF HYPOFRACTIONATION AND ADAPTIVE TREATMENT PLANNING TO PROPEL MARKET
 
 
 
 
 
11.2.3
PARTICLE THERAPY
 
 
 
 
 
 
 
11.2.3.1
ADVANCEMENTS IN TREATMENT PLANNING SYSTEMS AND EXPANSION OF PROTON THERAPY FACILITIES TO DRIVE ADOPTION
 
 
 
 
 
11.2.4
3D CONFORMAL RADIOTHERAPY
 
 
 
 
 
 
 
11.2.4.1
CONTINUED UTILIZATION IN RESOURCE-CONSTRAINED SETTINGS TO SUPPORT ADOPTION OF 3D-CRT
 
 
 
 
 
11.2.5
STEREOTACTIC RADIOTHERAPY
 
 
 
 
 
 
 
11.2.5.1
EXPANDING CLINICAL APPLICATIONS AND HYPOFRACTIONATED TREATMENT APPROACHES TO PROPEL ADOPTION
 
 
 
 
 
11.2.6
OTHER EBRT PROCEDURES
 
 
 
 
 
11.3
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
 
 
 
 
 
 
 
11.3.1
LDR BRACHYTHERAPY
 
 
 
 
 
 
 
11.3.1.1
LOW RISK OF RADIATION EXPOSURE TO SURROUNDING TISSUES TO DRIVE ADOPTION
 
 
 
 
 
11.3.2
HDR BRACHYTHERAPY
 
 
 
 
 
 
 
11.3.2.1
ADVANCEMENTS IN IMAGE-GUIDED PLANNING AND DOSE OPTIMIZATION TO DRIVE GROWTH
 
 
 
 
 
11.3.3
PDR BRACHYTHERAPY
 
 
 
 
 
 
 
11.3.3.1
BETTER RADIATION SAFETY, EASIER PROSPECTIVE PLANNING, AND PRECISE DOSE SHAPING TO DRIVE ADOPTION
 
 
 
12
RADIOTHERAPY MARKET, BY TECHNOLOGY
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 24 Data Tables
 
 
 
 
 
127
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
EXTERNAL BEAM RADIOTHERAPY
 
 
 
 
 
 
 
12.2.1
LINACS
 
 
 
 
 
 
 
12.2.1.1
CONVENTIONAL LINACS
 
 
 
 
 
 
 
 
12.2.1.1.1
LONG TREATMENT DURATION TO LIMIT ADOPTION
 
 
 
 
12.2.1.2
STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS
 
 
 
 
 
 
 
 
12.2.1.2.1
CYBERKNIFE
 
 
 
 
 
 
12.2.1.2.2
GAMMA KNIFE
 
 
 
 
 
 
12.2.1.2.3
TOMOTHERAPY
 
 
 
 
12.2.1.3
MRI LINACS
 
 
 
 
 
 
 
 
12.2.1.3.1
REAL-TIME IMAGING ADVANTAGE TO PROPEL GROWTH
 
 
 
12.2.2
PARTICLE THERAPY
 
 
 
 
 
 
 
12.2.2.1
CYCLOTRONS
 
 
 
 
 
 
 
 
12.2.2.1.1
ENHANCED OUTCOMES AND OTHER ADVANTAGES TO BOOST ADOPTION
 
 
 
 
12.2.2.2
SYNCHROTRONS
 
 
 
 
 
 
 
 
12.2.2.2.1
INCREASING INVESTMENTS IN SYNCHROTRON FACILITIES TO DRIVE MARKET
 
 
 
 
12.2.2.3
SYNCHROCYCLOTRONS
 
 
 
 
 
 
 
 
12.2.2.3.1
COMPACT SYNCHROCYCLOTRON INNOVATIONS SUPPORT ADOPTION DESPITE INFRASTRUCTURE CHALLENGES
 
 
 
12.2.3
CONVENTIONAL COBALT-60 TELETHERAPY
 
 
 
 
 
 
 
12.2.3.1
COMPLEX DOSE DELIVERY PLANNING AND RADIATION EXPOSURE TO LIMIT MARKET ADOPTION
 
 
 
 
12.3
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
 
 
 
 
 
 
 
12.3.1
SEEDS
 
 
 
 
 
 
 
12.3.1.1
ADVERSE EFFECTS ASSOCIATED WITH BRACHYTHERAPY SEEDS TO LIMIT ADOPTION
 
 
 
 
 
12.3.2
AFTERLOADERS
 
 
 
 
 
 
 
12.3.2.1
PROPER POSITIONING AND BETTER CONTROL OF ISOTOPES IN MODERN AFTERLOADERS TO DRIVE DEMAND
 
 
 
 
 
12.3.3
IORT SYSTEMS
 
 
 
 
 
 
 
12.3.3.1
GROWING CLINICAL EVIDENCE SUPPORTING LONG-TERM EFFICACY TO DRIVE ADOPTION
 
 
 
 
 
12.3.4
APPLICATORS
 
 
 
 
 
 
 
12.3.4.1
HIGH RISK OF RADIATION EXPOSURE IN MANUAL APPLICATORS TO LIMIT GROWTH
 
 
 
13
RADIOTHERAPY MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 3 Data Tables
 
 
 
 
 
148
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
HOSPITALS
 
 
 
 
 
 
 
13.2.1
INCREASING ADOPTION OF AI-ENABLED AND PRECISION RADIATION THERAPY SOLUTIONS TO DRIVE MARKET
 
 
 
 
 
13.3
INDEPENDENT RADIOTHERAPY CENTERS
 
 
 
 
 
 
 
13.3.1
EXPANSION OF RADIOTHERAPY INFRASTRUCTURE AND COMMUNITY-BASED CANCER CARE TO PROPEL MARKET
 
 
 
 
14
RADIOTHERAPY MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 142 Data Tables.
 
 
 
 
 
152
 
14.1
INTRODUCTION
 
 
 
 
 
 
14.2
NORTH AMERICA
 
 
 
 
 
 
 
14.2.1
US
 
 
 
 
 
 
 
14.2.1.1
FAVORABLE REIMBURSEMENT SCENARIO TO DRIVE GROWTH
 
 
 
 
 
14.2.2
CANADA
 
 
 
 
 
 
 
14.2.2.1
FAVORABLE INITIATIVES FROM GOVERNMENT AND PRIVATE ORGANIZATIONS TO BOOST MARKET
 
 
 
 
14.3
EUROPE
 
 
 
 
 
 
 
14.3.1
GERMANY
 
 
 
 
 
 
 
14.3.1.1
AVAILABILITY OF NOVEL RADIOTHERAPY PRODUCTS TO DRIVE MARKET
 
 
 
 
 
14.3.2
FRANCE
 
 
 
 
 
 
 
14.3.2.1
PRESENCE OF ADVANCED HEALTHCARE SYSTEMS TO AUGMENT GROWTH
 
 
 
 
 
14.3.3
UK
 
 
 
 
 
 
 
14.3.3.1
GROWING ADOPTION OF ADVANCED RADIOTHERAPY TECHNOLOGIES AND RISING CANCER BURDEN TO DRIVE MARKET
 
 
 
 
 
14.3.4
SPAIN
 
 
 
 
 
 
 
14.3.4.1
ADOPTION OF ADVANCED RADIOTHERAPY TECHNOLOGIES TO DRIVE MARKET
 
 
 
 
 
14.3.5
ITALY
 
 
 
 
 
 
 
14.3.5.1
RISING ADOPTION OF ADVANCED RADIOTHERAPY TECHNOLOGIES AND STRONG RESEARCH ECOSYSTEM TO SUPPORT MARKET GROWTH
 
 
 
 
 
14.3.6
REST OF EUROPE
 
 
 
 
 
14.4
ASIA PACIFIC
 
 
 
 
 
 
 
14.4.1
JAPAN
 
 
 
 
 
 
 
14.4.1.1
FAVORABLE REIMBURSEMENT POLICIES TO PROPEL MARKET
 
 
 
 
 
14.4.2
CHINA
 
 
 
 
 
 
 
14.4.2.1
PRECISION ONCOLOGY INVESTMENTS TO DRIVE MARKET
 
 
 
 
 
14.4.3
INDIA
 
 
 
 
 
 
 
14.4.3.1
GROWING CANCER BURDEN, INFRASTRUCTURE INVESTMENTS, AND ADVANCED TECHNOLOGY ADOPTION TO DRIVE MARKET
 
 
 
 
 
14.4.4
SOUTH KOREA
 
 
 
 
 
 
 
14.4.4.1
RISING INVESTMENTS IN HEAVY-ION THERAPY INFRASTRUCTURE TO PROPEL MARKET
 
 
 
 
 
14.4.5
AUSTRALIA
 
 
 
 
 
 
 
14.4.5.1
GROWING CANCER CASES TO FUEL MARKET
 
 
 
 
 
14.4.6
REST OF ASIA PACIFIC
 
 
 
 
 
14.5
LATIN AMERICA
 
 
 
 
 
 
 
14.5.1
BRAZIL
 
 
 
 
 
 
 
14.5.1.1
INCREASING PREVALENCE OF CANCER TO FUEL MARKET
 
 
 
 
 
14.5.2
MEXICO
 
 
 
 
 
 
 
14.5.2.1
EXPANDING ONCOLOGY INFRASTRUCTURE AND PRECISION RADIOTHERAPY ADOPTION TO DRIVE GROWTH
 
 
 
 
 
14.5.3
REST OF LATIN AMERICA
 
 
 
 
 
14.6
MIDDLE EAST & AFRICA
 
 
 
 
 
 
 
14.6.1
GCC COUNTRIES
 
 
 
 
 
 
 
14.6.1.1
INCREASING INVESTMENTS IN ADVANCED ONCOLOGY INFRASTRUCTURE TO PROPEL MARKET
 
 
 
 
 
14.6.2
REST OF MIDDLE EAST & AFRICA
 
 
 
 
15
COMPETITIVE LANDSCAPE
Discover strategic insights and market positioning of key radiotherapy players through 2025.
 
 
 
 
 
220
 
15.1
INTRODUCTION
 
 
 
 
 
 
15.2
KEY PLAYER STRATEGIES/RIGHT TO WIN
 
 
 
 
 
 
 
15.2.1
KEY PLAYER COMPETITIVE STRATEGIES IN RADIOTHERAPY MARKET, JANUARY 2022–MAY 2026
 
 
 
 
 
15.3
REVENUE ANALYSIS, 2021–2025
 
 
 
 
 
 
 
15.4
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
15.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
15.5.1
STARS
 
 
 
 
 
 
15.5.2
EMERGING LEADERS
 
 
 
 
 
 
15.5.3
PERVASIVE PLAYERS
 
 
 
 
 
 
15.5.4
PARTICIPANTS
 
 
 
 
 
 
15.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
15.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
15.5.5.2
REGION FOOTPRINT
 
 
 
 
 
 
15.5.5.3
TECHNOLOGY FOOTPRINT
 
 
 
 
 
 
15.5.5.4
APPLICATION FOOTPRINT
 
 
 
 
 
 
15.5.5.5
END-USER FOOTPRINT
 
 
 
 
15.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
 
15.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
15.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
15.6.3
DYNAMIC COMPANIES
 
 
 
 
 
 
15.6.4
STARTING BLOCKS
 
 
 
 
 
 
15.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
15.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES, 2025
 
 
 
 
 
 
15.6.5.2
COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES, 2025
 
 
 
 
15.7
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
 
15.8
BRAND COMPARISON
 
 
 
 
 
 
 
15.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
15.9.1
PRODUCT LAUNCHES & APPROVALS
 
 
 
 
 
 
15.9.2
DEALS
 
 
 
 
 
 
15.9.3
EXPANSIONS
 
 
 
 
16
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
242
 
16.1
KEY PLAYERS
 
 
 
 
 
 
 
16.1.1
SIEMENS HEALTHINEERS AG
 
 
 
 
 
 
 
16.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
16.1.1.2
PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
16.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
16.1.1.3.1
PRODUCT APPROVALS
 
 
 
 
 
 
16.1.1.3.2
DEALS
 
 
 
 
16.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
16.1.1.4.1
KEY STRENGTHS
 
 
 
 
 
 
16.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
16.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
 
 
 
16.1.2
ELEKTA
 
 
 
 
 
 
16.1.3
ACCURAY INCORPORATED
 
 
 
 
 
 
16.1.4
IBA WORLDWIDE
 
 
 
 
 
 
16.1.5
VIEWRAY SYSTEMS, INC.
 
 
 
 
 
 
16.1.6
GT MEDICAL TECHNOLOGIES, INC.
 
 
 
 
 
 
16.1.7
HITACHI HIGH-TECH CORPORATION
 
 
 
 
 
 
16.1.8
SUMITOMO HEAVY INDUSTRIES, LTD.
 
 
 
 
 
 
16.1.9
ZEISS GROUP
 
 
 
 
 
 
16.1.10
MIM SOFTWARE INC.
 
 
 
 
 
 
16.1.11
PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
 
 
 
 
 
 
16.1.12
PROVISION HEALTHCARE
 
 
 
 
 
 
16.1.13
MEVION MEDICAL SYSTEMS
 
 
 
 
 
 
16.1.14
KONINKLIJKE PHILIPS N.V.
 
 
 
 
 
16.2
OTHER PLAYERS
 
 
 
 
 
 
 
16.2.1
SHINVA MEDICAL INSTRUMENT CO., LTD.
 
 
 
 
 
 
16.2.2
BRAINLAB AG
 
 
 
 
 
 
16.2.3
RAYSEARCH LABORATORIES
 
 
 
 
 
 
16.2.4
INTRAOP MEDICAL, INC.
 
 
 
 
 
 
16.2.5
OPTIVUS PROTON THERAPY, INC.
 
 
 
 
 
 
16.2.6
BEBIG MEDICAL
 
 
 
 
 
 
16.2.7
P-CURE
 
 
 
 
 
 
16.2.8
THERAGENICS CORPORATION
 
 
 
 
 
 
16.2.9
PROTOM INTERNATIONAL
 
 
 
 
 
 
16.2.10
DOSISOFT SA
 
 
 
 
 
 
16.2.11
ISOAID, LLC
 
 
 
 
 
 
16.2.12
MAGNETTX ONCOLOGY SOLUTIONS LTD.
 
 
 
 
17
RESEARCH METHODOLOGY
 
 
 
 
 
301
 
17.1
RESEARCH DATA
 
 
 
 
 
 
 
17.1.1
SECONDARY DATA
 
 
 
 
 
 
 
17.1.1.1
OBJECTIVES OF SECONDARY RESEARCH
 
 
 
 
 
 
17.1.1.2
LIST OF SECONDARY SOURCES
 
 
 
 
 
17.1.2
PRIMARY DATA
 
 
 
 
 
 
 
17.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
17.1.2.2
KEY INDUSTRY INSIGHTS
 
 
 
 
17.2
MARKET ESTIMATION METHODOLOGY
 
 
 
 
 
 
 
17.2.1
BOTTOM-UP APPROACH
 
 
 
 
 
 
17.2.2
REVENUE MAPPING-BASED MARKET ESTIMATION
 
 
 
 
 
 
17.2.3
USAGE-BASED MARKET ESTIMATION
 
 
 
 
 
 
17.2.4
PRIMARY RESEARCH VALIDATION
 
 
 
 
 
 
17.2.5
TOP-DOWN APPROACH
 
 
 
 
 
17.3
DATA TRIANGULATION AND MARKET BREAKDOWN
 
 
 
 
 
 
17.4
MARKET SHARE ASSESSMENT
 
 
 
 
 
 
17.5
RESEARCH ASSUMPTIONS
 
 
 
 
 
 
17.6
RESEARCH LIMITATIONS
 
 
 
 
 
 
17.7
RISK ASSESSMENT
 
 
 
 
 
 
 
17.7.1
RISK ASSESSMENT ANALYSIS
 
 
 
 
18
APPENDIX
 
 
 
 
 
316
 
18.1
DISCUSSION GUIDE
 
 
 
 
 
 
18.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
18.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
18.4
RELATED REPORTS
 
 
 
 
 
 
18.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
RADIOTHERAPY MARKET: INCLUSION/EXCLUSION DETAILS
 
 
 
 
 
 
TABLE 2
DIFFERENT TYPES OF EXTERNAL BEAM RADIATION THERAPY (EBRT) TECHNIQUES AND ASSOCIATED ADVANTAGES AND DISADVANTAGES
 
 
 
 
 
 
TABLE 3
TREATMENT-RELATED EFFECTS AND TOXICITY CONCERNS
 
 
 
 
 
 
TABLE 4
RADIOTHERAPY MARKET: CURRENT UNMET NEEDS
 
 
 
 
 
 
TABLE 5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
 
TABLE 6
RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
TABLE 7
AVERAGE SELLING PRICE TREND OF RADIOTHERAPY SYSTEMS, BY REGION, 2023–2025
 
 
 
 
 
 
TABLE 8
IMPORT DATA FOR HS CODE 902214-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD)
 
 
 
 
 
 
TABLE 9
EXPORT DATA FOR HS CODE 902214-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD)
 
 
 
 
 
 
TABLE 10
RADIOTHERAPY MARKET: KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
TABLE 11
US-ADJUSTED RECIPROCAL TARIFF RATES IN MEDTECH INDUSTRY
 
 
 
 
 
 
TABLE 12
TARIFF-INDUCED PRICE INCREASES FOR HEALTHCARE PRODUCTS
 
 
 
 
 
 
TABLE 13
RADIOTHERAPY MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2020–2026
 
 
 
 
 
 
TABLE 14
KEY CLINICAL TRIALS EVALUATING ARTIFICIAL INTELLIGENCE IN RADIOTHERAPY
 
 
 
 
 
 
TABLE 15
KEY AI USE CASES AND MARKET POTENTIAL IN RADIOTHERAPY MARKET
 
 
 
 
 
 
TABLE 16
KEY CLINICAL CASE STUDIES OF ARTIFICIAL INTELLIGENCE APPLICATIONS IN RADIOTHERAPY
 
 
 
 
 
 
TABLE 17
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 18
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 19
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 20
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 21
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 22
US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
 
 
 
 
 
 
TABLE 23
CLASS II PRESCRIBED EQUIPMENT CERTIFICATES
 
 
 
 
 
 
TABLE 24
JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
 
 
 
 
 
 
TABLE 25
INDIA: MEDICAL DEVICE CLASSIFICATION UNDER CDSCO
 
 
 
 
 
 
TABLE 26
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY SYSTEMS
 
 
 
 
 
 
TABLE 27
KEY BUYING CRITERIA FOR RADIOTHERAPY SYSTEMS
 
 
 
 
 
 
TABLE 28
RADIOTHERAPY MARKET: CURRENT UNMET NEEDS
 
 
 
 
 
 
TABLE 29
RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 30
RADIOTHERAPY SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 31
RADIOTHERAPY SOFTWARE & SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 32
RADIOTHERAPY MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 33
EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 34
EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 35
EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR PROSTATE CANCER, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR BREAST CANCER, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 37
EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR LUNG CANCER, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 38
EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR HEAD & NECK CANCER, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 39
EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET FOR COLORECTAL CANCER, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 40
OTHER EBRT APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 41
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 43
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR PROSTATE CANCER, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR BREAST CANCER, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR CERVICAL CANCER, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR PENILE CANCER, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET FOR OTHER IBRT APPLICATIONS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
RADIOTHERAPY MARKET, BY PROCEDURE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
IMAGE-GUIDED RADIOTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
INTENSITY-MODULATED RADIOTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
PARTICLE THERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
3D CONFORMAL RADIOTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
STEREOTACTIC RADIOTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
OTHER EBRT PROCEDURES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
LDR BRACHYTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
HDR BRACHYTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
PDR BRACHYTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
LINACS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
CONVENTIONAL LINACS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
CYBERKNIFE MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 72
GAMMA KNIFE MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
TOMOTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
MRI LINACS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
PARTICLE THERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
CYCLOTRONS THERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
SYNCHROTRONS THERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
SYNCHROCYCLOTRONS THERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
CONVENTIONAL COBALT-60 TELETHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
SEEDS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
AFTERLOADERS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
IORT SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
APPLICATORS MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
RADIOTHERAPY MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
RADIOTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
NORTH AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
NORTH AMERICA: RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
NORTH AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 94
NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
NORTH AMERICA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 96
NORTH AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
NORTH AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
NORTH AMERICA: RADIOTHERAPY MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
US: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
US: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
US: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
US: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
CANADA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
CANADA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
CANADA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
CANADA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
EUROPE: RADIOTHERAPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
EUROPE: RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
EUROPE: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
EUROPE: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
EUROPE: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
EUROPE: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
EUROPE: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
EUROPE: EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
EUROPE: RADIOTHERAPY MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
GERMANY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
GERMANY: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
GERMANY: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
GERMANY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
FRANCE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
FRANCE: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
FRANCE: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
FRANCE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
UK: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
UK: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
UK: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
UK: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
SPAIN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
SPAIN: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
SPAIN: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
SPAIN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
ITALY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
ITALY: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
ITALY: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
ITALY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
REST OF EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
REST OF EUROPE: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
REST OF EUROPE: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
REST OF EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
ASIA PACIFIC: RADIOTHERAPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
ASIA PACIFIC: RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
ASIA PACIFIC: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
ASIA PACIFIC: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
ASIA PACIFIC: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
ASIA PACIFIC: RADIOTHERAPY MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
JAPAN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
JAPAN: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
JAPAN: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
JAPAN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
CHINA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
CHINA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
CHINA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
CHINA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
INDIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
INDIA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
INDIA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
INDIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
SOUTH KOREA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
SOUTH KOREA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
SOUTH KOREA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
SOUTH KOREA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
AUSTRALIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
AUSTRALIA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
AUSTRALIA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
AUSTRALIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
REST OF ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
REST OF ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
REST OF ASIA PACIFIC: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
REST OF ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
LATIN AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
LATIN AMERICA: RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
LATIN AMERICA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
LATIN AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
LATIN AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
LATIN AMERICA: RADIOTHERAPY MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
BRAZIL: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
BRAZIL: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
BRAZIL: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
BRAZIL: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
MEXICO: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
MEXICO: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
MEXICO: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
MEXICO: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
REST OF LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
REST OF LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
REST OF LATIN AMERICA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
REST OF LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY SYSTEM AND SOFTWARE & SERVICE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
MIDDLE EAST & AFRICA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
MIDDLE EAST & AFRICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
MIDDLE EAST & AFRICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
GCC COUNTRIES: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
GCC COUNTRIES: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
GCC COUNTRIES: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
GCC COUNTRIES: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
REST OF MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
REST OF MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
REST OF MIDDLE EAST & AFRICA: LINACS MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
REST OF MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY TECHNOLOGIES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN RADIOTHERAPY MARKET, JANUARY 2022–MAY 2026
 
 
 
 
 
 
TABLE 233
RADIOTHERAPY MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 234
RADIOTHERAPY MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 235
RADIOTHERAPY MARKET: TECHNOLOGY FOOTPRINT
 
 
 
 
 
 
TABLE 236
RADIOTHERAPY MARKET: APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 237
RADIOTHERAPY MARKET: END-USER FOOTPRINT
 
 
 
 
 
 
TABLE 238
RADIOTHERAPY MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
 
 
 
 
 
 
TABLE 239
RADIOTHERAPY MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 240
RADIOTHERAPY MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2026
 
 
 
 
 
 
TABLE 241
RADIOTHERAPY MARKET: DEALS, JANUARY 2022–MAY 2026
 
 
 
 
 
 
TABLE 242
RADIOTHERAPY MARKET: EXPANSIONS, JANUARY 2022–MAY 2026
 
 
 
 
 
 
TABLE 243
SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 244
SIEMENS HEALTHINEERS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 245
SIEMENS HEALTHINEERS AG: PRODUCT APPROVALS, JANUARY 2022–MAY 2026
 
 
 
 
 
 
TABLE 246
SIEMENS HEALTHINEERS AG: DEALS, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 247
ELEKTA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 248
ELEKTA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 249
ELEKTA: PRODUCTS LAUNCHES & APPROVALS, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 250
ELEKTA: DEALS, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 251
ELEKTA: EXPANSIONS, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 252
ACCURAY INCORPORATED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 253
ACCURAY INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 254
ACCURAY INCORPORATED: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 255
ACCURAY INCORPORATED: DEALS, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 256
ACCURAY INCORPORATED: EXPANSIONS, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 257
IBA WORLDWIDE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 258
IBA WORLDWIDE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 259
IBA WORLDWIDE: PRODUCT LAUNCHES, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 260
IBA WORLDWIDE: DEALS, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 261
VIEWRAY SYSTEMS, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 262
VIEWRAY SYSTEMS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 263
VIEWRAY SYSTEMS, INC.: PRODUCT APPROVALS, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 264
VIEWRAY SYSTEMS, INC.: DEALS, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 265
GT MEDICAL TECHNOLOGIES, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 266
GT MEDICAL TECHNOLOGIES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 267
HITACHI HIGH-TECH CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 268
HITACHI HIGH-TECH CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 269
HITACHI HIGH-TECH CORPORATION: DEALS, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 270
SUMITOMO HEAVY INDUSTRIES, LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 271
SUMITOMO HEAVY INDUSTRIES, LTD.: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
 
 
 
 
 
 
TABLE 272
ZEISS GROUP : COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 273
ZEISS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 274
ZEISS GROUP: PRODUCT LAUNCHES, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 275
MIM SOFTWARE INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 276
MIM SOFTWARE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 277
MIM SOFTWARE INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 278
MIM SOFTWARE INC.: DEALS, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 279
PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 280
PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: PRODUCTS/SOLUTIONS/ SERVICES OFFERED
 
 
 
 
 
 
TABLE 281
PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: PRODUCT LAUNCHES , JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 282
PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: DEALS, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 283
PROVISION HEALTHCARE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 284
PROVISION HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 285
MEVION MEDICAL SYSTEMS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 286
MEVION MEDICAL SYSTEMS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 287
MEVION MEDICAL SYSTEMS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 288
MEVION MEDICAL SYSTEMS: DEALS, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 289
KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 290
KONINKLIJKE PHILIPS N.V.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
 
 
 
 
 
 
TABLE 291
KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES, JANUARY 2022−MAY 2026
 
 
 
 
 
 
TABLE 292
SHINVA MEDICAL INSTRUMENT CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 293
BRAINLAB AG: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 294
RAYSEARCH LABORATORIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 295
INTRAOP MEDICAL, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 296
OPTIVUS PROTON THERAPY, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 297
BEBIG MEDICAL: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 298
P-CURE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 299
THERAGENICS CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 300
PROTOM INTERNATIONAL: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 301
DOSISOFT SA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 302
ISOAID, LLC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 303
MAGNETTX ONCOLOGY SOLUTIONS LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 304
RADIOTHERAPY MARKET: RESEARCH ASSUMPTIONS
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
RADIOTHERAPY MARKET SEGMENTATION AND REGIONAL SCOPE
 
 
 
 
 
 
FIGURE 2
DURATION COVERED
 
 
 
 
 
 
FIGURE 3
MARKET SCENARIO
 
 
 
 
 
 
FIGURE 4
GLOBAL RADIOTHERAPY MARKET, 2024–2031
 
 
 
 
 
 
FIGURE 5
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN RADIOTHERAPY MARKET, 2022–2026
 
 
 
 
 
 
FIGURE 6
DISRUPTIONS INFLUENCING GROWTH OF RADIOTHERAPY MARKET
 
 
 
 
 
 
FIGURE 7
HIGH-GROWTH SEGMENTS IN RADIOTHERAPY MARKET, 2026–2031
 
 
 
 
 
 
FIGURE 8
ASIA PACIFIC TO REGISTER HIGHEST CAGR IN RADIOTHERAPY MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 9
ADVANCEMENTS IN AI AND ADAPTIVE RADIOTHERAPY ENHANCE TREATMENT PRECISION
 
 
 
 
 
 
FIGURE 10
NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET SHARE DURING STUDY PERIOD
 
 
 
 
 
 
FIGURE 11
EXTERNAL BEAM RADIATION THERAPY SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2025
 
 
 
 
 
 
FIGURE 12
CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 13
RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 14
RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 15
RADIOTHERAPY MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 16
RADIOTHERAPY MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 17
AVERAGE SELLING PRICE TREND OF RADIOTHERAPY SYSTEMS, BY REGION, 2023–2025 (USD)
 
 
 
 
 
 
FIGURE 18
IMPORT DATA FOR HS CODE 902214-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025
 
 
 
 
 
 
FIGURE 19
EXPORT DATA FOR HS CODE 902214-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025
 
 
 
 
 
 
FIGURE 20
RADIOTHERAPY MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
 
 
 
 
 
 
FIGURE 21
RADIOTHERAPY MARKET: INVESTMENT & FUNDING SCENARIO, 2019–2023
 
 
 
 
 
 
FIGURE 22
RADIOTHERAPY MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023
 
 
 
 
 
 
FIGURE 23
VALUE OF INVESTOR DEALS IN RADIOTHERAPY MARKET, BY KEY PLAYER, 2019–2023
 
 
 
 
 
 
FIGURE 24
PATENT ANALYSIS FOR RADIOTHERAPY MARKET, JANUARY 2016–DECEMBER 2025
 
 
 
 
 
 
FIGURE 25
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY SYSTEMS
 
 
 
 
 
 
FIGURE 26
KEY BUYING CRITERIA FOR RADIOTHERAPY SYSTEMS
 
 
 
 
 
 
FIGURE 27
NORTH AMERICA: RADIOTHERAPY MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 28
ASIA PACIFIC: RADIOTHERAPY MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 29
REVENUE ANALYSIS OF KEY PLAYERS IN RADIOTHERAPY MARKET, 2021−2025
 
 
 
 
 
 
FIGURE 30
MARKET SHARE ANALYSIS OF KEY PLAYERS IN RADIOTHERAPY MARKET, 2025
 
 
 
 
 
 
FIGURE 31
RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 32
RADIOTHERAPY MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 33
RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 34
EV/EBITDA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 35
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 36
RADIOTHERAPY MARKET: BRAND COMPARATIVE ANALYSIS
 
 
 
 
 
 
FIGURE 37
SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 38
ELEKTA: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 39
ACCURAY INCORPORATED: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 40
IBA WORLDWIDE: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 41
HITACHI HIGH-TECH CORPORATION: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 42
SUMITOMO HEAVY INDUSTRIES, LTD.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 43
ZEISS GROUP: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 44
KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
 
 
 
 
 
 
FIGURE 45
RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 46
BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
 
 
 
 
 
 
FIGURE 47
BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
 
 
 
 
 
 
FIGURE 48
RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
 
 
 
 
 
 
FIGURE 49
RADIOTHERAPY MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
 
 
 
 
 
 
FIGURE 50
MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2025)
 
 
 
 
 
 
FIGURE 51
RADIOTHERAPY MARKET: MARKET SIZE ESTIMATION METHODOLOGY
 
 
 
 
 
 
FIGURE 52
MARKET SIZE ESTIMATION: TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 53
DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 

 

Methodology

This study involved the extensive use of both primary and secondary sources. Exhaustive secondary research was done to collect information on the radiotherapy industry. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the radiotherapy market's segments and subsegments. The research process involved examining various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and key players' strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, Companies House documents, investor presentations, and SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the radiotherapy market. It was also used to obtain important information about key players, market classification & segmentation according to industry trends, down to the bottom-most level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

The market for companies offering radiotherapy products is derived from secondary data available through paid and unpaid sources, by analyzing the product portfolios of the major companies in the ecosystem and rating them by performance and quality. Various sources were consulted during the secondary research process to identify and collect information for this study. Secondary research was used to obtain critical information on the industry's value chain, the total pool of key players, market classification, and segmentation from market- and technology-oriented perspectives.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the radiotherapy market. The primary sources from the demand side include OEMs, private and contract testing organizations, and service providers, among others. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends & key market dynamics.

After the complete market engineering (calculations for market statistics, market breakdown, market estimation, market forecasting and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at fill primary research was also conducted to identify the segmentation types industry trends competitive landscape of radiotherapy offered by various market players and key market dynamics such as drivers, restraints, opportunities, challenges, industry trends and key players strategies.

In the complete market engineering process, the top-down and bottom-up approaches were extensively used, along with several data regulation methods, to perform market estimation and forecasting across the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analyses were conducted across the entire market engineering process to identify key insights throughout the report.

A breakdown of the primary respondents is provided below:

Radiotherapy Market
 Size, and Share

Note 1: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note 2: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 2 billion, Tier 2 = USD 50 million to USD 2 billion, and Tier 3 = <USD 50 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the radiotherapy market. These methods were also used extensively to estimate the size of various market segments.

To determine the size of the global radiotherapy market, revenue share analysis was employed with the leading players. In this case, key market players have been identified, and their radiotherapy product business revenues have been determined using insights gathered during the primary and secondary research phases. Secondary research included the study of top market players' annual and financial reports. On the other hand, primary research included in-depth interviews with key opinion leaders, particularly chief executive officers, directors, and key marketing executives.

Radiotherapy Market : Top-Down and Bottom-Up Approach

Radiotherapy Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall market size through the market size estimation process described above, the global radiotherapy market was segmented. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the radiotherapy market was validated using both top-down and bottom-up approaches.

Market Definition

The radiotherapy market includes a range of products, solutions, technologies, and services that utilize high-energy radiation for therapeutic purposes. This encompasses various types of radiation, such as X-ray, gamma, electron, and particle radiation. The technologies segment of radiotherapy features systems designed to treat diseases, primarily cancer. This includes external beam radiotherapy methods like LINAC, MRI-LINAC, and cobalt-60 teletherapy. Additionally, internal radiotherapy solutions, commonly known as brachytherapy, are also part of this market segment. Other components of the radiotherapy market include software for imaging and treatment planning. Furthermore, the market provides maintenance and training services related to radiotherapy technologies.

Key Stakeholders

  • Radiotherapy product manufacturing companies
  • Distributors, suppliers, and commercial service providers
  • Healthcare service providers
  • Clinical research organizations (CROs)
  • Radiotherapy service providers
  • Radiotherapy product distributors
  • Medical research laboratories
  • Cancer care centers
  • Cancer research organizations
  • Academic medical centers and universities
  • Market research and consulting firms

Report Objectives

  • To define, describe, and forecast the radiotherapy market based on offering, technology, application, procedure, end user, and region
  • To provide detailed information regarding the major factors influencing the growth potential of the global radiotherapy market (drivers, restraints, opportunities, challenges, and trends)
  • To analyze the micromarkets for individual growth trends, prospects, and contributions to the global radiotherapy market
  • To analyze key growth opportunities in the global radiotherapy market for key stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of market segments and/or subsegments with respect to five major regions: North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain, and the Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and the Rest of Asia Pacific), Latin America (Brazil, Mexico, and the Rest of Latin America), and the Middle East & Africa (GCC Countries and the Rest of Middle East & Arica)
  • To profile the key players in the global radiotherapy market and comprehensively analyze their market shares and core competencies
  • To track and analyze the competitive developments undertaken in the global radiotherapy market, such as agreements, expansions, and product launches

Available customizations:

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the present global radiotherapy market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top 16 companies

Company Information

  • Detailed analysis and profiling of additional market players (up to 15)

Geographic Analysis

  • Further breakdown of the Rest of Europe radiotherapy market into Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among others
  • Further breakdown of the Rest of Asia Pacific radiotherapy market into Singapore, Taiwan, New Zealand, the Philippines, Malaysia, and other APAC countries
  • Further breakdown of the Rest of Latin America radiotherapy market into Argentina, Chile, Peru, and Colombia, among others

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Radiotherapy Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Radiotherapy Market

DMCA.com Protection Status
popup img